JINKOSOLAR HOLDING CO-ADR (JKS)

US47759T1007 - ADR

23.8  -0.22 (-0.92%)

After market: 23.8 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to JKS. JKS was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. While JKS is still in line with the averages on profitability rating, there are concerns on its financial health. JKS has a correct valuation and a medium growth rate.



5

1. Profitability

1.1 Basic Checks

JKS had positive earnings in the past year.
Each year in the past 5 years JKS has been profitable.
In multiple years JKS reported negative operating cash flow during the last 5 years.

1.2 Ratios

JKS has a Return On Assets (2.54%) which is in line with its industry peers.
With a decent Return On Equity value of 17.10%, JKS is doing good in the industry, outperforming 79.63% of the companies in the same industry.
JKS has a Return On Invested Capital of 6.28%. This is in the better half of the industry: JKS outperforms 69.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JKS is significantly below the industry average of 11.24%.
The 3 year average ROIC (3.11%) for JKS is below the current ROIC(6.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.54%
ROE 17.1%
ROIC 6.28%
ROA(3y)1.38%
ROA(5y)1.29%
ROE(3y)9.23%
ROE(5y)7.93%
ROIC(3y)3.11%
ROIC(5y)3.95%

1.3 Margins

With a Profit Margin value of 2.90%, JKS perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
In the last couple of years the Profit Margin of JKS has grown nicely.
With a Operating Margin value of 5.67%, JKS perfoms like the industry average, outperforming 57.41% of the companies in the same industry.
JKS's Operating Margin has improved in the last couple of years.
JKS has a Gross Margin of 16.05%. This is amonst the worse of the industry: JKS underperforms 84.26% of its industry peers.
JKS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.67%
PM (TTM) 2.9%
GM 16.05%
OM growth 3Y1.62%
OM growth 5Y16.57%
PM growth 3Y64.32%
PM growth 5Y12.37%
GM growth 3Y-2.97%
GM growth 5Y2.72%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JKS is still creating some value.
Compared to 1 year ago, JKS has more shares outstanding
JKS has more shares outstanding than it did 5 years ago.
JKS has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that JKS is in the distress zone and has some risk of bankruptcy.
JKS has a worse Altman-Z score (1.20) than 69.44% of its industry peers.
A Debt/Equity ratio of 2.30 is on the high side and indicates that JKS has dependencies on debt financing.
JKS has a Debt to Equity ratio of 2.30. This is amonst the worse of the industry: JKS underperforms 92.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACC1.62
WACC3.88%

2.3 Liquidity

JKS has a Current Ratio of 1.04. This is a normal value and indicates that JKS is financially healthy and should not expect problems in meeting its short term obligations.
JKS has a worse Current ratio (1.04) than 88.89% of its industry peers.
A Quick Ratio of 0.81 indicates that JKS may have some problems paying its short term obligations.
JKS has a worse Quick ratio (0.81) than 87.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.81

6

3. Growth

3.1 Past

The earnings per share for JKS have decreased strongly by -71.24% in the last year.
JKS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 56.68% yearly.
JKS shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.08%.
JKS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.50% yearly.
EPS 1Y (TTM)-71.24%
EPS 3Y50.74%
EPS 5Y56.68%
EPS Q2Q%-97.16%
Revenue 1Y (TTM)42.08%
Revenue growth 3Y50.05%
Revenue growth 5Y36.5%
Sales Q2Q%-19.96%

3.2 Future

Based on estimates for the next years, JKS will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.44% on average per year.
JKS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y-92.34%
EPS Next 2Y-56.56%
EPS Next 3Y-25.55%
EPS Next 5Y9.44%
Revenue Next Year-16.04%
Revenue Next 2Y-5.37%
Revenue Next 3Y1.84%
Revenue Next 5Y2.71%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.32, the valuation of JKS can be described as reasonable.
98.15% of the companies in the same industry are more expensive than JKS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.73. JKS is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 12.19, which indicates a correct valuation of JKS.
Based on the Price/Forward Earnings ratio, JKS is valued cheaper than 93.52% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, JKS is valued a bit cheaper.
Industry RankSector Rank
PE 8.32
Fwd PE 12.19

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as JKS's earnings are expected to decrease with -25.55% in the coming years.
PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2Y-56.56%
EPS Next 3Y-25.55%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.32%, JKS is a good candidate for dividend investing.
JKS's Dividend Yield is rather good when compared to the industry average which is at 2.31. JKS pays more dividend than 100.00% of the companies in the same industry.
JKS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 12.32%

5.2 History

JKS is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

DP0%
EPS Next 2Y-56.56%
EPS Next 3Y-25.55%

JINKOSOLAR HOLDING CO-ADR

NYSE:JKS (12/20/2024, 8:20:19 PM)

After market: 23.8 0 (0%)

23.8

-0.22 (-0.92%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)N/A N/A
Inst Owners27.21%
Inst Owner Change-6.65%
Ins Owners3.82%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts50.67
Price Target25.6 (7.56%)
Short Float %13.7%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield 12.32%
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-Date08-15 2024-08-15 (1.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.75%
Min EPS beat(2)-52.08%
Max EPS beat(2)127.59%
EPS beat(4)3
Avg EPS beat(4)151.74%
Min EPS beat(4)-52.08%
Max EPS beat(4)419.8%
EPS beat(8)4
Avg EPS beat(8)28.39%
EPS beat(12)7
Avg EPS beat(12)149.99%
EPS beat(16)9
Avg EPS beat(16)113.33%
Revenue beat(2)0
Avg Revenue beat(2)-85.59%
Min Revenue beat(2)-85.86%
Max Revenue beat(2)-85.33%
Revenue beat(4)0
Avg Revenue beat(4)-85.63%
Min Revenue beat(4)-85.86%
Max Revenue beat(4)-85.33%
Revenue beat(8)3
Avg Revenue beat(8)-30.09%
Revenue beat(12)4
Avg Revenue beat(12)-22.63%
Revenue beat(16)6
Avg Revenue beat(16)-17.12%
PT rev (1m)1.56%
PT rev (3m)-3.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-40.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.23%
Valuation
Industry RankSector Rank
PE 8.32
Fwd PE 12.19
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)2.86
EY12.02%
EPS(NY)1.95
Fwd EY8.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS358.78
BVpS60.94
TBVpS53.71
PEG (NY)N/A
PEG (5Y)0.15
Profitability
Industry RankSector Rank
ROA 2.54%
ROE 17.1%
ROCE 11.97%
ROIC 6.28%
ROICexc 7.86%
ROICexgc 8.15%
OM 5.67%
PM (TTM) 2.9%
GM 16.05%
FCFM N/A
ROA(3y)1.38%
ROA(5y)1.29%
ROE(3y)9.23%
ROE(5y)7.93%
ROIC(3y)3.11%
ROIC(5y)3.95%
ROICexc(3y)3.83%
ROICexc(5y)5.06%
ROICexgc(3y)3.93%
ROICexgc(5y)5.22%
ROCE(3y)6.28%
ROCE(5y)7.66%
ROICexcg growth 3Y7.76%
ROICexcg growth 5Y17.64%
ROICexc growth 3Y7.69%
ROICexc growth 5Y17.77%
OM growth 3Y1.62%
OM growth 5Y16.57%
PM growth 3Y64.32%
PM growth 5Y12.37%
GM growth 3Y-2.97%
GM growth 5Y2.72%
F-ScoreN/A
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.81
Altman-Z 1.2
F-ScoreN/A
WACC3.88%
ROIC/WACC1.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.24%
EPS 3Y50.74%
EPS 5Y56.68%
EPS Q2Q%-97.16%
EPS Next Y-92.34%
EPS Next 2Y-56.56%
EPS Next 3Y-25.55%
EPS Next 5Y9.44%
Revenue 1Y (TTM)42.08%
Revenue growth 3Y50.05%
Revenue growth 5Y36.5%
Sales Q2Q%-19.96%
Revenue Next Year-16.04%
Revenue Next 2Y-5.37%
Revenue Next 3Y1.84%
Revenue Next 5Y2.71%
EBIT growth 1Y669.02%
EBIT growth 3Y52.48%
EBIT growth 5Y59.12%
EBIT Next Year-38.35%
EBIT Next 3Y2.9%
EBIT Next 5Y20.24%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A